{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T02:59:50Z","timestamp":1760151590699,"version":"build-2065373602"},"reference-count":42,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2005,1,1]],"date-time":"2005-01-01T00:00:00Z","timestamp":1104537600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2005,1,1]],"date-time":"2005-01-01T00:00:00Z","timestamp":1104537600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Anxiety Disorders"],"published-print":{"date-parts":[[2005]]},"DOI":"10.1016\/j.janxdis.2004.08.001","type":"journal-article","created":{"date-parts":[[2004,9,29]],"date-time":"2004-09-29T11:08:38Z","timestamp":1096456118000},"page":"818-825","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["NAG level differences in panic disorder and agoraphobia"],"prefix":"10.1016","volume":"19","author":[{"given":"Michael J.","family":"Garvey","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"suffix":"Jr.","given":"Russell","family":"Noyes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"1213","key":"10.1016\/j.janxdis.2004.08.001_bib1","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1056\/NEJM198311173092004","article-title":"Increased excretion of N-acetyl-beta-glucosaminidase in essential hypertension and its decline with antihypertensive therapy","volume":"309","author":"Alderman","year":"1983","journal-title":"New England Journal of Medicine"},{"issue":"4","key":"10.1016\/j.janxdis.2004.08.001_bib2","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/0010-440X(87)90071-X","article-title":"On the longitudinal course of panic disorder: development history and predictors of phobic complications","volume":"28","author":"Aronson","year":"1987","journal-title":"Comprehensive Psychiatry"},{"issue":"5","key":"10.1016\/j.janxdis.2004.08.001_bib3","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1001\/archpsyc.1988.01800290027004","article-title":"Alprazolam in panic disorder and agoraphobia: results from a multicenter trial. I. Efficacy in short-term treatment","volume":"45","author":"Ballenger","year":"1988","journal-title":"Archives of General Psychiatry"},{"issue":"11","key":"10.1016\/j.janxdis.2004.08.001_bib4","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1001\/archpsyc.1986.01800110015003","article-title":"Agoraphobia with panic attacks. Development, diagnostic stability, and course of illness","volume":"43","author":"Breier","year":"1986","journal-title":"Archives of General Psychiatry"},{"issue":"613","key":"10.1016\/j.janxdis.2004.08.001_bib5","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1136\/bmj.1.6010.613","article-title":"Salicylates and renal function in rheumatiod arthritis","volume":"1","author":"Burry","year":"1976","journal-title":"British Medical Journal"},{"issue":"127","key":"10.1016\/j.janxdis.2004.08.001_bib6","first-page":"127","article-title":"Hypothesis relating serotonergic dysfunction to the etiology and treatment of panic and generalized anxiety disorders","volume":"1","author":"Charney","year":"1990","journal-title":"American Psychiatric Press Inc., Washington, DC"},{"year":"1979","series-title":"Diagnostic significance of enzymes and protein in urine","author":"Dubach","key":"10.1016\/j.janxdis.2004.08.001_bib7"},{"issue":"12","key":"10.1016\/j.janxdis.2004.08.001_bib8","doi-asserted-by":"crossref","first-page":"1564","DOI":"10.1176\/ajp.145.12.1564","article-title":"Prodromal symptoms in panic disorder with agoraphobia","volume":"145","author":"Fava","year":"1988","journal-title":"American Journal of Psychiatry"},{"issue":"2","key":"10.1016\/j.janxdis.2004.08.001_bib9","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/0165-0327(92)90038-8","article-title":"Prodromal symptoms in panic disorder with agoraphobia: a replication study","volume":"26","author":"Fava","year":"1992","journal-title":"Journal of Affective Disorders"},{"issue":"3","key":"10.1016\/j.janxdis.2004.08.001_bib10","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/0022-3956(93)90034-Y","article-title":"An association between the lysosomal enzyme NAG and urinary free cortisol and platelet imipramine binding","volume":"27","author":"Garvey","year":"1993","journal-title":"Journal of Psychiatric Research"},{"issue":"247","key":"10.1016\/j.janxdis.2004.08.001_bib11","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1111\/j.1600-0447.1988.tb05117.x","article-title":"Elevation of the renal enzyme N-acetyl-beta-glucosaminidase in affective disorders and chemical dependence","volume":"77","author":"Garvey","year":"1988","journal-title":"Acta Psychiatrica Scandinavica"},{"issue":"2","key":"10.1016\/j.janxdis.2004.08.001_bib12","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1159\/000119217","article-title":"The association of the serotonin metabolite, 5-HIAA, to the lysosomal enzyme N-acetyl-beta-glucosaminidase","volume":"32","author":"Garvey","year":"1995","journal-title":"Neuropsychobiology"},{"issue":"529","key":"10.1016\/j.janxdis.2004.08.001_bib13","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/0010-440X(84)90052-X","article-title":"The relationship of panic disorder to agoraphobia","volume":"25","author":"Garvey","year":"1984","journal-title":"Comprehensive Psychiatry"},{"issue":"420","key":"10.1016\/j.janxdis.2004.08.001_bib14","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1192\/bjp.141.4.420","article-title":"Use of renal enzymes to evaluate nephrotoxicity in lithium treated patients","volume":"141","author":"Garvey","year":"1982","journal-title":"British Journal of Psychiatry"},{"issue":"50","key":"10.1016\/j.janxdis.2004.08.001_bib15","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1111\/j.2044-8341.1959.tb00467.x","article-title":"The assessment of anxiety states by rating","volume":"32","author":"Hamilton","year":"1959","journal-title":"British Journal of Medical Psychology"},{"issue":"10","key":"10.1016\/j.janxdis.2004.08.001_bib16","doi-asserted-by":"crossref","first-page":"1496","DOI":"10.1176\/ajp.150.10.1496","article-title":"Agoraphobia without panic: clinical reappraisal of an epidemiologic finding","volume":"150","author":"Horwath","year":"1993","journal-title":"American Journal of Psychiatry"},{"year":"1991","series-title":"The role of serotonin in the regulation of anxiety","author":"Kahn","key":"10.1016\/j.janxdis.2004.08.001_bib17"},{"issue":"211","key":"10.1016\/j.janxdis.2004.08.001_bib18","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/0165-1781(88)90064-9","article-title":"Relationship of urinary free cortisol levels in patients with panic disorder to symptoms of depression and agoraphobia","volume":"24","author":"Kathol","year":"1988","journal-title":"Psychiatry Research"},{"issue":"751","key":"10.1016\/j.janxdis.2004.08.001_bib19","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1542\/peds.62.5.751","article-title":"Enzymuria as a marker of renal injury and disease: studies of N-acetyl-beta-glucosaminidase in the general population","volume":"62","author":"Kunin","year":"1978","journal-title":"Pediatrics"},{"issue":"11","key":"10.1016\/j.janxdis.2004.08.001_bib20","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1001\/archpsyc.1989.01810110042006","article-title":"Onset of panic disorder with agoraphobia. Toward an integrated model","volume":"46","author":"Lelliott","year":"1989","journal-title":"Archives of General Psychiatry"},{"issue":"803","key":"10.1016\/j.janxdis.2004.08.001_bib21","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1016\/S0140-6736(78)92586-2","article-title":"N-acteyl-beta-glucosaminidase: a new approach to screening hypertensive patients for renal disease","volume":"2","author":"Mansell","year":"1978","journal-title":"Lancet"},{"issue":"135","key":"10.1016\/j.janxdis.2004.08.001_bib22","first-page":"135","article-title":"Evaluation of urinary enzyme patterns in patients with kidney disease and primary benign hypertension","volume":"9","author":"Maruhn","year":"1979","journal-title":"Current Problems in Clinical Biochemistry"},{"year":"1972","series-title":"Profile of Mood States (Manual)","author":"McNair","key":"10.1016\/j.janxdis.2004.08.001_bib23"},{"year":"1994","series-title":"Panic disorder: a critical analysis","author":"McNally","key":"10.1016\/j.janxdis.2004.08.001_bib24"},{"issue":"3","key":"10.1016\/j.janxdis.2004.08.001_bib25","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1001\/archpsyc.1986.01800030037004","article-title":"Relationship between panic disorder and agoraphobia. A family study","volume":"43","author":"Noyes","year":"1986","journal-title":"Archives of General Psychiatry"},{"key":"10.1016\/j.janxdis.2004.08.001_bib26","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/0887-6185(87)90018-1","article-title":"Is agorophobia a variant of panic disorder or a seperate illness?","volume":"1","author":"Noyes","year":"1987","journal-title":"Journal of Anxiety Disorders"},{"year":"1998","series-title":"The anxiety disorders","author":"Noyes","key":"10.1016\/j.janxdis.2004.08.001_bib27"},{"issue":"99","key":"10.1016\/j.janxdis.2004.08.001_bib28","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/0300-483X(82)90092-0","article-title":"Urinary enzymes, nephrotoxicity, and renal disease","volume":"23","author":"Price","year":"1982","journal-title":"Toxicology"},{"issue":"65","key":"10.1016\/j.janxdis.2004.08.001_bib29","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/0009-8981(70)90375-X","article-title":"The excretion of N-acetyl-beta-glucosaminidase and beta-glactosidase following surgery to the kidney","volume":"27","author":"Price","year":"1970","journal-title":"Clinica Chimica Acta"},{"issue":"155","key":"10.1016\/j.janxdis.2004.08.001_bib30","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/0009-8981(80)90207-7","article-title":"Increased serum alpha-l-fuctosidase and beta-N-acetylglucosaminidase activities in diabetic, cirrhotic, and gastric cancer patients","volume":"103","author":"Reglero","year":"1980","journal-title":"Clinica Chimica Acta"},{"year":"1986","series-title":"The anxiety disease","author":"Sheehan","key":"10.1016\/j.janxdis.2004.08.001_bib31"},{"year":"1982","series-title":"Structured clinical interview for DSM-III","author":"Spitzer","key":"10.1016\/j.janxdis.2004.08.001_bib32"},{"issue":"1","key":"10.1016\/j.janxdis.2004.08.001_bib33","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/0010-440X(93)90033-Z","article-title":"The phenomenology of panic attacks in panic disorder with and without agoraphobia","volume":"34","author":"Starcevic","year":"1993","journal-title":"Comprehensive Psychiatry"},{"issue":"2","key":"10.1016\/j.janxdis.2004.08.001_bib34","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1097\/00004850-200008002-00002","article-title":"Serotonin and anxiety: current models","volume":"15","author":"Stein","year":"2000","journal-title":"International Clinical Psychopharmacology"},{"issue":"5","key":"10.1016\/j.janxdis.2004.08.001_bib35","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/0005-7967(85)90108-1","article-title":"Temporal relationship between panic attack onset and phobic avoidance in agoraphobia","volume":"23","author":"Thyer","year":"1985","journal-title":"Behaviour Research and Therapy"},{"issue":"2","key":"10.1016\/j.janxdis.2004.08.001_bib36","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/0010-440X(85)90041-0","article-title":"A comparison of panic disorder and agoraphobia with panic attacks","volume":"26","author":"Thyer","year":"1985","journal-title":"Comprehensive Psychiatry"},{"issue":"333","key":"10.1016\/j.janxdis.2004.08.001_bib37","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/0009-8981(75)90245-4","article-title":"Automated assay of N-acetyl-beta-glucosaminidase in a normal pathological human urine","volume":"62","author":"Tucker","year":"1975","journal-title":"Clinica Chimica Acta"},{"issue":"29","key":"10.1016\/j.janxdis.2004.08.001_bib38","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/0009-8981(80)90430-1","article-title":"Characterization of human N-acetyl-b-glucosaminidase isoenzymes as an indicator of tissue damage in disease","volume":"102","author":"Tucker","year":"1980","journal-title":"Clinica Chimica Acta"},{"issue":"1","key":"10.1016\/j.janxdis.2004.08.001_bib39","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/0278-5846(85)90178-2","article-title":"Longitudinal course of panic disorder: clinical and biological considerations","volume":"9","author":"Uhde","year":"1985","journal-title":"Progress in Neuro-psychopharmacology & Biological Psychiatry"},{"issue":"85","key":"10.1016\/j.janxdis.2004.08.001_bib40","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/0009-8981(76)90475-7","article-title":"A note on the practical aspects of the N-acetyl-beta-glucosaminidase in human urine","volume":"69","author":"Wellwood","year":"1976","journal-title":"Clinica Chimica Acta"},{"issue":"459","key":"10.1016\/j.janxdis.2004.08.001_bib41","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/0009-8981(79)90227-4","article-title":"Serum and urine N-acetyl-beta-glucosaminidase in diabetics on diagnosis and subsequent treatment, and stable insulin dependent diabetics","volume":"92","author":"Whiting","year":"1979","journal-title":"Clinica Chimica Acta"},{"issue":"671","key":"10.1016\/j.janxdis.2004.08.001_bib42","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1016\/0009-8981(65)90149-X","article-title":"Plasma N-acteyl-beta-glucosaminidase and beta-glucuronidase in health and disease","volume":"12","author":"Wollen","year":"1965","journal-title":"Clinica Chimica Acta"}],"container-title":["Journal of Anxiety Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0887618504000751?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0887618504000751?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T22:47:58Z","timestamp":1760136478000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0887618504000751"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005]]},"references-count":42,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2005]]}},"alternative-id":["S0887618504000751"],"URL":"https:\/\/doi.org\/10.1016\/j.janxdis.2004.08.001","relation":{},"ISSN":["0887-6185"],"issn-type":[{"type":"print","value":"0887-6185"}],"subject":[],"published":{"date-parts":[[2005]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"NAG level differences in panic disorder and agoraphobia","name":"articletitle","label":"Article Title"},{"value":"Journal of Anxiety Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.janxdis.2004.08.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2004 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}